41 results
DEFA14A
VIR
Vir Biotechnology Inc
8 May 20
Additional proxy soliciting materials
4:10pm
– May 8, 2020 – Vir Biotechnology, Inc. (Nasdaq: VIR) announced today that, due to public health and safety concerns related to theCOVID-19 global
8-K
EX-99.2
VIR
Vir Biotechnology Inc
6 Jul 20
Our mission is to create a world without infectious disease
6:32am
materials and we and our third-party manufacturers and suppliers must comply with environmental, health and safety laws and regulations, which can … hazardous compounds and wastes. We and our manufacturers and suppliers are subject to environmental, health and safety laws and regulations governing, among
8-K
EX-99.1
VIR
Vir Biotechnology Inc
3 Nov 22
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2022 Financial Results
4:06pm
population. Initial data are expected in mid-2023.
HIV – advancing novel solutions for this intractable public health challenge
Safety and immunology data
10-Q
tyq6rxb61ps7xk 3llo
19 Nov 19
Quarterly report
4:06pm
DRS/A
EX-10.21
c9fqpa3 ilouie6
7 Aug 19
Draft registration statement (amended)
12:00am